Cyclerion Therapeutics (CYCN) is scheduled to report Q2 earnings on August 4, 2026.
Cyclerion Therapeutics has beaten EPS estimates in 2 consecutive quarters.
Over the last 2 quarters, Cyclerion Therapeutics has averaged an EPS surprise of 0.46% and a revenue surprise of 9.25%.
Analyze the earnings history of Cyclerion Therapeutics using advanced sorting and filters.
The chart below shows Cyclerion Therapeutics's reported EPS compared to analyst estimates over recent quarters.
The chart below shows Cyclerion Therapeutics's reported revenue compared to analyst estimates over recent quarters.
Cyclerion Therapeutics (CYCN) is scheduled to report earnings on August 4, 2026. The last reported earnings were for reported on May 12, 2026 for Q1.
The Actual EPS was $-0.76, which missed the estimate of $0.00.
The Actual Revenue was $0.00, which hit the estimate of $0.00.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2026-03-30 | $-0.19 | $-0.38 | 50.0 % |
| Q4 | 2023-03-22 | $-3.20 | $-5.60 | 42.9 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2026-03-30 | $1.02M | $100.00K | 925.0 % |